Research graph
References from Effets des phytoestrogènes sur le pronostic et des marqueurs hormonaux du cancer du sein : une revue systématique d’essais cliniques randomisés. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 · External reference
Unresolved reference
2026 · External reference
A basic review on estrogen receptor signaling pathways in breast cancer
10.3390/ijms24076834 · 2023 · External reference
A review on phytoestrogens: current status and future direction
10.1002/ptr.7861 · 2023 · External reference
Daidzein and genistein: natural phytoestrogens with potential applications in hormone replacement therapy
10.3390/ijms26146973 · 2025 · External reference
Oestrogen receptor beta in breast cancer prognosis and treatment
10.1016/j.maturitas.2025.108762 · 2025 · External reference
Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies
10.1093/jncics/pkad104 · 2024 · External reference
Dietary phytoestrogens and biomarkers of their intake in relation to cancer survival and recurrence: a comprehensive systematic review with meta-analysis
10.1093/nutrit/nuaa043 · 2021 · External reference
Dietary isoflavone intake and breast cancer prognosis: a prospective analysis and meta-analysis
10.1080/01635581.2023.2279220 · 2024 · External reference
Postdiagnosis dietary factors, supplement use and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis
10.1002/ijc.34321 · 2023 · External reference
Lignans intake and enterolactone concentration and prognosis of breast cancer: a systematic review and meta-analysis
10.7150/jca.55477 · 2021 · External reference
Dietary factors and breast cancer prognosis among breast cancer survivors: a systematic review and meta-analysis of cohort studies
10.3390/cancers13215329 · 2021 · External reference
Unresolved reference
2024 · External reference
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
10.1186/2046-4053-4-1 · 2015 · External reference
Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status
2019 · External reference
RoB 2: a revised tool for assessing risk of bias in randomised trials
10.1136/bmj.l4898 · 2019 · External reference
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
10.1186/1471-2288-14-135 · 2014 · External reference
Abstract P5-08-20: Comparative study of the gut microbiome of newly diagnosed postmenopausal breast cancer patients and healthy controls, and pilot study on the acceptability of soy milk in the patient group [Abstract]
10.1158/1557-3265.sabcs24-p5-08-20 · 2025 · External reference
Unresolved reference
2002 · External reference
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial
10.1158/1940-6207.capr-11-0251 · 2012 · External reference
The effect of diet on breast cancer recurrence: the DIANA-5 randomized trial
10.1158/1078-0432.ccr-23-1615 · 2024 · External reference
Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen
10.1007/s10549-020-05534-4 · 2020 · External reference
Short-term soy and probiotic supplementation does not markedly affect concentrations of reproductive hormones in postmenopausal women with and without histories of breast cancer
10.1089/acm.2005.11.1067 · 2005 · External reference
A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients
2003 · External reference
Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women
10.1210/jc.2003-030362 · 2003 · External reference
Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer
10.1210/jc.2003-031166 · 2004 · External reference
Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women
10.1016/j.fertnstert.2004.09.003 · 2005 · External reference
Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women
10.1210/jc.2003-032229 · 2004 · External reference
Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones
10.1097/01.gme.0000191210.13115.90 · 2006 · External reference
Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women
10.1097/01.gme.0000236935.51325.4d · 2007 · External reference
A review of the clinical and epidemiologic evidence relevant to the impact of postdiagnosis isoflavone intake on breast cancer outcomes
10.1007/s13668-025-00640-5 · 2025 · External reference
Comprehensive review of isoflavones and lignans in the prophylaxis and treatment of breast cancer
2026 · External reference
Meta-analyses of lignans and enterolignans in relation to breast cancer risk
10.3945/ajcn.2009.28573 · 2010 · External reference
Metabolism of endogenous and exogenous estrogens in women
10.1016/j.jsbmb.2024.106539 · 2024 · External reference
Unresolved reference
2017 · External reference
Unresolved reference
External reference
Unresolved reference
2025 · External reference
Unresolved reference
2024 · External reference
